US 10813929
Treating cancer with ATR inhibitors
granted A61KA61K31/4965A61K31/497
Quick answer
US patent 10813929 (Treating cancer with ATR inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/4965, A61K31/497, A61K31/555, A61K31/7048